Want to join the conversation?
Pharma company $LLY said that European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has positively recommended the granting of a conditional marketing authorization for olaratumab, in combination with doxorubicin. This drug is used for the treatment of adults with advanced soft tissue sarcoma, a type of cancer.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?